Curmumin (CRN)-NLC nanoparticles were administrated to nude mice with LNCaP prostate cancer xenografts and demonstrated substantial tumor volume suppression with no weight loss compared to pure CRN.
[Drug Delivery and Translational Research]
Sorry, but the selected Zotpress account can't be found.
